Clinical Trials Browser

Phase 1 × Lymphoma × VTX-2337 × Clear all

NCT00688415 2019-09-25

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

Phase 1 Completed

Lymphoma